ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
125
publications
Top publications
401
views
Most viewed
0
reviews
Latest reviews
0
follows
Top followed users
0
followers
Follow
0
edited collections
All edited
0
followed collections
All followed
Publications
125
Quality of life (QOL) with ribociclib (RIB) plus aromatase inhibitor (AI) versus abemaciclib (ABE) plus AI as first-line (1L) treatment (tx) of hormone receptor-positive/human epidermal growth factor receptor–negative (HR+/HER2−) advanced breast cancer (ABC), assessed via matching-adjusted indirect comparison (MAIC)
Authors:
HS Rugo
,
J O’Shaughnessy
,
KL Jhaveri
…
A meta-analysis of overall survival data from three randomized trials of bevacizumab (BV) and first-line chemotherapy as treatment for patients with metastatic breast cancer (MBC).
Authors:
J O'SHAUGHNESSY
,
D. MILES
,
R. GRAY
…
Patients with slowly proliferative early breast cancer have low recurrence rates in a phase 3 adjuvant trial of capecitabine
Authors:
J O’Shaughnessy
All publications
Record
: found
Orcid
: not found
Profile
: not found
J O’Shaughnessy
Actions
Follow
New message
Share
Twitter
Sina Weibo
Facebook
Email
Statistics